bioAffinity Technologies Statistics
NASDAQ: BIAFHealth CareBiotechnology: Commercial Physical & Biological ResarchUSD
4.73-0.915 (-16.22%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
bioAffinity Technologies by the numbers
bioAffinity Technologies has a market capitalization of $5.5 million based on 1.17M shares outstanding. With trailing EPS of $-109.35, bioAffinity Technologies is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 36.3% below its 50-day average and 76.9% below its 200-day average.
Average daily trading volume is 3.73M shares, or about $17.6 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
BIAF valuation vs. peer median
| Metric | BIAF | Peer median | Difference |
|---|---|---|---|
| Market cap | $5.51M | $573.06M | -99% |
| Avg. volume | 3.73M | 667.22K | +459% |
Peer median across 8 companies: ISPC, ONMD, MXCT, NRC, OABI, ICLR, CRL, MEDP.
Valuation
- Market cap
- $5.51M
- EPS (TTM)
- $-109.35
- Shares outstanding
- 1.17M
Price and trading
- Previous close
- 5.64
- Open
- 5.44
- Day range
- 4.68 – 5.48
- 52-week range
- 4.56 – 80.70
- Beta
- —
- Volume
- 647.24K
- Average volume
- 3.73M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 14, 2025
Additional statistics
- Market Cap
- 5.51M
- Forward Pe
- -7.87
- Eps
- -109.35
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 80.70
- Week52 Low
- 4.56
- Avg Volume
- 3.73M
- Shares Outstanding
- 1.17M
- Ma50
- 7.42
- Ma200
- 20.47
- Earnings Date
- Aug 14, 2025
- Pct From52w High
- -94.14%
- Pct From52w Low
- 3.62%